ロード中...
Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Hepatocellular carcinoma is the most common primary liver cancer and the fourth leading cause of cancer death worldwide. A total of 70–80% of patients are diagnosed at an advanced stage with a dismal prognosis. Sorafenib had been the standard care for almost a decade until 2018 when the Food and Dru...
保存先:
| 出版年: | Medicina (Kaunas) |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6843273/ https://ncbi.nlm.nih.gov/pubmed/31627433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55100698 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|